Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

TUCSON, Ariz., May 8, 2024 /PRNewswire/ — Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024. “During the quarter we installed our first pre-clinical trial site demonstrating our ability to successfully…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.